Description

Eylea 40mg Injection (Aflibercept) – Uses, Side Effects, Dosage & Price in Pakistan

Eylea 40mg Injection (Aflibercept) is a prescription eye medicine used to treat several retinal conditions that can affect vision. It belongs to a group of medicines known as vascular endothelial growth factor (VEGF) inhibitors. By blocking VEGF activity, Eylea helps reduce abnormal blood-vessel growth and leakage of fluid inside the eye.

Eylea is given as an intravitreal injection, meaning that it is injected directly into the eye by a qualified eye specialist under appropriate sterile conditions. It is not an injection that patients should administer themselves.

Eylea is used for conditions including wet age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema and diabetic retinopathy. It is also approved for retinopathy of prematurity in appropriate patients.

People searching for Eylea 40mg Injection in Pakistan can contact Impo Medic for current information regarding imported product availability, sourcing and price. Treatment must always be prescribed and administered by an appropriately qualified ophthalmologist.

Eylea 40mg Injection (Aflibercept) Used

Eylea is primarily used to treat retinal diseases involving abnormal blood vessels or leakage of fluid within the retina.

Wet Age-Related Macular Degeneration

Wet age-related macular degeneration, commonly called wet AMD, develops when abnormal blood vessels grow underneath the retina and leak blood or fluid.

This leakage can damage the macula, which is responsible for detailed central vision. Eylea blocks VEGF and helps control abnormal blood-vessel growth and leakage.

Diabetic Macular Edema

Diabetic macular edema (DME) is a complication of diabetes in which damaged retinal blood vessels leak fluid into the macula.

This can cause swelling and changes in vision. Anti-VEGF medicines such as Eylea are used to reduce this leakage and macular swelling.

Diabetic Retinopathy

Diabetic retinopathy occurs when long-term diabetes damages blood vessels in the retina. Depending on its severity, abnormal blood vessels and other retinal changes can threaten vision.

Eylea may be prescribed to treat diabetic retinopathy in appropriate patients.

Macular Edema Following Retinal Vein Occlusion

Retinal vein occlusion occurs when a vein carrying blood away from the retina becomes blocked. Fluid may then accumulate in the macula and affect vision.

Eylea can be used to treat macular edema following retinal vein occlusion.

Retinopathy of Prematurity

Eylea also has an approved indication for retinopathy of prematurity (ROP), a potentially serious retinal condition affecting premature infants.

Treatment decisions and dosing for infants are specialist matters and should only be managed by appropriately experienced ophthalmologists.

How Does Eylea 40mg Injection Work?

Aflibercept acts as a VEGF inhibitor.

VEGF is a naturally occurring protein involved in the development of blood vessels. Excessive VEGF activity in certain retinal diseases can cause abnormal blood vessels to grow and make existing vessels more permeable.

This can result in fluid leakage, retinal swelling and vision problems.

Aflibercept binds VEGF-A and placental growth factor (PlGF), preventing them from activating their receptors. By reducing this signaling, Eylea helps control abnormal blood-vessel growth and vascular leakage.

The treatment does not work like a conventional painkiller or tablet. Its effects occur directly within the eye, which is why it must be administered by an eye specialist.

Eylea 40mg Injection Dosage and Administration

Eylea treatment schedules vary according to the eye condition being treated.

For adults with wet AMD, the recommended regimen for the 40mg/mL formulation is generally 2mg (0.05mL) injected into the affected eye every four weeks for the first three months, followed by 2mg every eight weeks. Some patients may require a different interval based on their response.

For macular edema following retinal vein occlusion, the recommended adult dose is generally 2mg (0.05mL) every four weeks.

For diabetic macular edema and diabetic retinopathy, the recommended regimen generally starts with 2mg every four weeks for the first five injections, followed by 2mg every eight weeks. Treatment schedules may subsequently be individualized.

These are general prescribing-information regimens and not personal dosage instructions.

Eylea must only be administered by a qualified healthcare professional experienced in intravitreal injections. Patients should follow the schedule established by their ophthalmologist.

How Eylea Injection Is Given

Eylea is injected into the vitreous cavity of the eye. The procedure is performed under controlled sterile conditions.

Before administering the injection, the healthcare professional takes appropriate measures to reduce the risk of infection. The eye is usually prepared with antiseptic treatment and appropriate anesthesia.

After administration, the doctor may monitor the eye and intraocular pressure as clinically appropriate.

Patients should never attempt to inject Eylea themselves.

Eylea 40mg Injection Side Effects

Like other intravitreal medicines, Eylea can cause side effects.

Common adverse reactions reported with Eylea include:

• Eye pain
• Redness or bleeding on the white part of the eye
• Increased pressure inside the eye
• Vitreous floaters
• Vitreous detachment
• Cataract

Some symptoms after an injection require urgent medical attention.

Contact an eye specialist promptly if you develop increasing eye pain, worsening redness, significant sensitivity to light, sudden changes in vision, flashes, a sudden increase in floaters or significant loss of vision.

These symptoms can indicate potentially serious eye complications that require rapid assessment.

Important Warnings and Precautions

Eylea treatment requires specialist medical supervision.

Eye Infection

Intravitreal injections carry a risk of endophthalmitis, a serious infection inside the eye.

Patients should immediately report symptoms suggesting infection after treatment.

Retinal Detachment

Retinal detachment can occur following intravitreal injections. Sudden flashes, new floaters, a shadow or curtain over part of the visual field, or sudden vision deterioration require urgent assessment.

Increased Eye Pressure

An increase in intraocular pressure can occur after Eylea administration. The treating ophthalmologist may therefore monitor pressure following an injection when clinically appropriate.

Retinal Vasculitis

Retinal vasculitis, including cases with vascular occlusion, has been reported following intravitreal injections. Significant new visual symptoms should be assessed promptly.

Blood-Clot-Related Events

VEGF inhibitors administered into the eye have a potential risk of arterial thromboembolic events. Patients should inform their healthcare professional about relevant cardiovascular or cerebrovascular history.

Who Should Not Receive Eylea?

Eylea is contraindicated in patients with:

• An infection in or around the eye
• Active inflammation inside the eye
• Known serious hypersensitivity to aflibercept or components of the product

Patients should tell their ophthalmologist about current eye infections, inflammation, previous reactions to eye injections and relevant medical conditions before treatment.

Pregnancy and Breastfeeding

Patients who are pregnant, planning pregnancy or breastfeeding should tell their doctor before receiving Eylea.

Because VEGF plays an important biological role, treatment decisions during pregnancy require careful assessment of potential benefits and risks.

Women of reproductive potential should follow their doctor’s instructions regarding contraception and pregnancy planning during treatment.

Storage and Handling

Eylea requires appropriate pharmaceutical storage and handling.

The product should remain in its original packaging and be stored according to the manufacturer’s instructions. Cold-chain requirements and protection from light are particularly important for injectable biological medicines.

Patients purchasing an imported product should verify:

• Original packaging
• Batch information
• Expiry date
• Correct storage conditions
• Product integrity

Eylea should be handled by healthcare professionals or appropriate pharmaceutical suppliers rather than stored or transported casually.

Eylea 40mg Injection Price in Pakistan

The Eylea 40mg Injection price in Pakistan may change according to international pricing, exchange rates, importer costs, supplier stock, transportation requirements and current market availability.

Because Eylea is an imported specialty medicine requiring appropriate handling and storage, a fixed online price may become outdated.

Patients and healthcare providers can contact Impo Medic to inquire about the current Eylea 40mg Injection price in Pakistan.

Before purchasing, confirm the exact product presentation, packaging, expiry information and current stock.

Eylea 40mg Injection Availability in Pakistan

Eylea 40mg Injection availability in Pakistan can vary because it is a specialized ophthalmic medicine and imported stock may not remain consistently available through every pharmacy.

Availability may depend on supplier inventory, import schedules and appropriate cold-chain arrangements.

Patients who have been prescribed Eylea and are having difficulty locating it can contact Impo Medic for updated information regarding availability and sourcing in Pakistan.

Since availability changes over time, patients should confirm current stock when the medicine is required rather than relying on an older online listing.

How to Buy Eylea 40mg Injection in Pakistan

Patients searching for Eylea 40mg Injection in Pakistan can contact Impo Medic to inquire about current price, availability and sourcing.

Before buying Eylea, customers should confirm:

• Correct medicine name
• Strength and formulation
• Original packaging
• Batch number
• Expiry date
• Storage and cold-chain conditions
• Current availability

Eylea is a prescription ophthalmic medicine and should only be purchased for use under the supervision of an eye specialist.

Impo Medic can assist customers with product availability and sourcing information, while the decision to prescribe, inject and determine the treatment schedule belongs to the treating ophthalmologist.

Why Choose Impo Medic?

Finding imported and specialty eye medicines in Pakistan can sometimes be challenging because availability, import schedules and prices can change.

Impo Medic helps customers in Pakistan inquire about imported and specialty medicines, including Eylea 40mg Injection. Customers can check current availability, sourcing information and updated pricing without relying on outdated product listings.

For injectable biological medicines, proper sourcing, packaging and storage are especially important. Impo Medic focuses on helping customers access clear product information and inquire about required specialty medicines in Pakistan.

Medical decisions remain with qualified healthcare professionals. Eylea should only be administered by an appropriately trained eye specialist.

Frequently Asked Questions

What is Eylea 40mg Injection (Aflibercept) used for?

Eylea is used to treat several retinal conditions, including wet age-related macular degeneration, diabetic macular edema, diabetic retinopathy and macular edema following retinal vein occlusion. It also has an approved indication for retinopathy of prematurity.

Is Eylea injected directly into the eye?

Yes. Eylea is administered as an intravitreal injection, which means it is injected into the vitreous cavity of the eye. The procedure must be performed by a qualified healthcare professional.

Can I inject Eylea myself?

No. Eylea is not a self-administered injection. It should only be administered under appropriate sterile conditions by an eye specialist experienced with intravitreal injections.

How often is Eylea 40mg Injection given?

The schedule depends on the condition being treated and the patient’s response. Some adult treatment regimens begin with monthly injections before moving to longer intervals. Your ophthalmologist determines the appropriate schedule.

What are the common side effects of Eylea?

Common reported adverse reactions include conjunctival hemorrhage, eye pain, cataract, vitreous detachment, floaters and increased intraocular pressure.

What symptoms require urgent attention after an Eylea injection?

Increasing eye pain, severe redness, sensitivity to light, sudden vision changes, flashes or a sudden increase in floaters should be reported promptly to an eye specialist.

What is Eylea 40mg Injection price in Pakistan?

The price can vary according to exchange rates, importer costs, stock and sourcing conditions. Contact Impo Medic for current Eylea 40mg Injection price information in Pakistan.

Is Eylea 40mg Injection available in Pakistan?

Availability can vary because Eylea is an imported specialty medicine. Customers can contact Impo Medic to check current availability in Pakistan.

How can I buy Eylea 40mg Injection in Pakistan?

Patients with an appropriate prescription can contact Impo Medic for information about current stock, price and sourcing. Treatment and administration should remain under an ophthalmologist’s supervision.